Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
Neon Therapeutics
Neon Therapeutics develops personalized vaccines and autologous T-cell therapies for cancer.
Sector
Subsector
Location
total rounds
total raised
Foghorn Therapeutics
Foghorn Therapeutics is developing therapies that change how genes turn "on" and "off".
Sector
Subsector
Location
total rounds
total raised
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing T cell engagers to treat cancer and other diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Oniria Therapeutics
Oniria Therapeutics develops precision oncology therapies to eliminate dormant tumor cells.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 12.09.2023. Their latest investor Partners Innovation Fund. Their latest round Series B
Section 32
Section 32 is a venture capital firm that invests in technology, healthcare, and life sciences.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
GV
GV is a venture capital firm that provides funding to innovative startups in various fields.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors18
Number of lead investors
Number of investors
Partners Innovation Fund
The Innovation Fund accelerates healthcare technology development and attracts external capital.
Sector
Subsector
Location
count Of Investments
count Of Exists
Bristol Myers Squibb
Bristol-Myers Squibb is a pharmaceuticals and nutritional products company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Johnson & Johnson Innovation – JJDC
JJDC helps innovative healthcare ideas become real solutions for patients.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Rosana Kapeller
Rosana Kapeller has over 15 years leadership experience in the biotechnology industry. Prior to joining Nimbus, she was Vice President, Research and Co-Founder of Aileron Therapeutics. From 2005 to 2009, Dr. Kapeller led the development of Aileron’s “Stapled Peptide” technology and the first stapled-peptide development candidate. Under her scientific leadership, Aileron secured $60 million in venture financing over its first 4 years. Prior to co-founding Aileron, Dr. Kapeller held positions of increasing responsibility at Millennium Pharmaceuticals most recently serving as Director, Department of Molecular and Cellular Biology. Rosana earned her M.D. from Rio de Janeiro State University in Brazil, and her Ph.D. from Tufts University Medical School, where she trained with Dr. Lewis C. Cantley. She conducted her post-doctoral research work at the Dana-Farber Cancer Institute where she was named a David Abraham Fellow in Pediatric Oncology.
current job
organization founded
Rosana Kapeller
Employee Profiles9
Keith Wilcoxen
Executive Vice President, Early Development
Nurjana Bachman
SVP, Corporate Development and Strategy
Wenyan Miao
VP of Biology and Preclinical Development
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range